| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/25/2005 | WO2005038464A3 Method for detecting the presence of an/or strain typing a tse |
| 08/25/2005 | WO2005037868A3 Methods of treating nfat-related disorders |
| 08/25/2005 | WO2005037194A3 Collagen interactions with prostate cancer cells |
| 08/25/2005 | WO2005031346A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor1 (adipor1) |
| 08/25/2005 | WO2005028510A3 Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity |
| 08/25/2005 | WO2005027963A3 METHODS AND COMPOSITIONS FOR THE GENERATION OF A PROTECTIVE IMMUNE RESPONSE AGAINTS SARS-CoV |
| 08/25/2005 | WO2005026692A3 Direct detection method for products of cellular metabolism using tof-sims |
| 08/25/2005 | WO2005026208A3 Chimeric gabab receptor |
| 08/25/2005 | WO2005022145A3 Remote contamination monitoring system for water supply network |
| 08/25/2005 | WO2005019831A3 Methods for reducing complexity of a sample using small epitope antibodies |
| 08/25/2005 | WO2005018797A8 Organised assembly of particles and the use thereof as a labelling system |
| 08/25/2005 | WO2005014793A3 Primary rat hepatocyte toxicity modeling |
| 08/25/2005 | WO2005012915A8 Method of detecting protein dirt on contact lens |
| 08/25/2005 | WO2005010200A3 Concurrent optimization in selection of primer and capture probe sets for nucleic acid analysis |
| 08/25/2005 | WO2005008443A3 Distributed sensor array for fluid contaminant monitoring |
| 08/25/2005 | WO2005007108A3 Asymmetric disulfides and methods of using same |
| 08/25/2005 | WO2005001485A3 Pem-3-like compositions and related methods thereof |
| 08/25/2005 | WO2004113500A3 B7s1: an immune modulator |
| 08/25/2005 | WO2004087069A3 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-PROLIFERATIVE AGENTS |
| 08/25/2005 | WO2004079331A3 Composition and method for immobilizing a substance on a solid-phase support |
| 08/25/2005 | WO2004074810A3 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 08/25/2005 | WO2004063215A3 Improve peptide charge state assignment in a high-throughput ms/ms environment |
| 08/25/2005 | WO2004058292A8 Methods and compositions for suppressing fibrocyte differentiation |
| 08/25/2005 | WO2004043988A8 Ptprk immunogenic peptide |
| 08/25/2005 | WO2004040300A3 Method of using animal models to predict adverse drug reactions |
| 08/25/2005 | US20050188427 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 08/25/2005 | US20050188426 Transgenic zebrafish for use as animal model in identifying modulators of heart function |
| 08/25/2005 | US20050187720 System and method for processing analyte sensor data |
| 08/25/2005 | US20050187718 Novel purified polypeptides from Streptococcus pneumoniae |
| 08/25/2005 | US20050187454 CMOS-process compatible high-DC surface coating for capacitive detection and stimulation of biological tissues |
| 08/25/2005 | US20050187444 Hand-held analytical device |
| 08/25/2005 | US20050187442 Blood sugar level measuring apparatus |
| 08/25/2005 | US20050187380 Method for treating Th2-mediated disease |
| 08/25/2005 | US20050187379 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/25/2005 | US20050187176 Method for inhibiting NF-kappa B signaling and use to treat or prevent human diseases |
| 08/25/2005 | US20050187150 mimics the binding of heparin and heparan sulfate to the fibroblast growth factor (FGF) ligand and receptor; ternary complex of:an FGF ligand polypeptide; an FGF receptor polypeptide; and a heparin agonist or antagonist |
| 08/25/2005 | US20050187141 Control of gene induced by oxidated lipids in human artery wall cells |
| 08/25/2005 | US20050186682 Apparatus and method for process monitoring |
| 08/25/2005 | US20050186681 An assay involving a testor fluid samples that includes a flow cell with a measurement chamber, a monitor device that directly monitors flow of a sample and a reagent into measurement chamber, a light source and a sensor positioned to receive an output beam from the flow cell; real time sensing |
| 08/25/2005 | US20050186678 Process for measuring mercury concentration within hydrocarbons |
| 08/25/2005 | US20050186670 Method of detecting error spot in DNA chip and system using the method |
| 08/25/2005 | US20050186665 Expressed ligand - vascular intercellular signaling molecule |
| 08/25/2005 | US20050186663 Cystine-knot fold protein |
| 08/25/2005 | US20050186658 Chimeric metabotropic glutamate receptors and uses thereof |
| 08/25/2005 | US20050186651 Incubating the drug candidate in vitro with a human liver microsome incubation mixture in the presence of dansylated glutathione; detecting any drug candidate-dansylated glutathione adducts formed using a fluorescence detector |
| 08/25/2005 | US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 08/25/2005 | US20050186647 Methods for identifying or monitoring a patient with increased risk of cardiovascular calcification |
| 08/25/2005 | US20050186646 Rapid assay to detect ADAMTS-13 activity |
| 08/25/2005 | US20050186645 Using amidase digestion to determine glycan composition and sequence of carbohydrate-containing molecules |
| 08/25/2005 | US20050186644 Contacting a sample comprising bladder cells taken from the subject with an antibody that specifically binds to nuclear matrix protein BLCA-4, wherein bladder cancer or risk of developing bladder cancer is indicated if sample contains nuclear matrix protein BLCA-4 |
| 08/25/2005 | US20050186643 Pin1 as a marker for abnormal cell growth |
| 08/25/2005 | US20050186642 Antibody composition for use in automated staining devices |
| 08/25/2005 | US20050186641 immobilized poly(amino acids) are labeled or detected on blots or on arrays of poly(amino acids), or are attached to immobilized aptamers; use in analysis and diagnostics |
| 08/25/2005 | US20050186640 Administering an agent which inhibits protein kinase A phosphorylation of a type 2 ryanodine receptor (RyR2); for treating a subject afflicted with exercise-induced or stress-induced cardiac arrhythmia |
| 08/25/2005 | US20050186638 Detecting modulators of brain membrane protein; obtained membrane protein incubated with ligand and labeled compound, measure level of binding |
| 08/25/2005 | US20050186637 Hybridoma cell for use in propagation of immunoglobulins for treatment and prevention of autoimmune, pancreatic, blood and cell proliferative disorders |
| 08/25/2005 | US20050186635 Self-assembled monolayer comprising ferrocene for use in monitoring redox potentials in biological fluids |
| 08/25/2005 | US20050186633 Intestinal fermentation model for use in development of functional foods |
| 08/25/2005 | US20050186631 Nematode PPPT-like sequences |
| 08/25/2005 | US20050186630 Extended tethering approach for rapid identification of ligands |
| 08/25/2005 | US20050186623 Recovering immunoglobulins from hybridoma cell line; bioreactor and heterologous gene expression |
| 08/25/2005 | US20050186619 Nucleic acid analysis using terminal-phosphate-labeled nucleotides |
| 08/25/2005 | US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 08/25/2005 | US20050186612 Dendritic cell receptor |
| 08/25/2005 | US20050186610 Tumor protein fusion for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/25/2005 | US20050186604 Using histone acetyltransferase (HAT) inhibitor as therapeutic tool in treatment of cell proliferative disorders |
| 08/25/2005 | US20050186598 Slide holder for use as support during scanning and/or screening of substrate comprising immobilized biopolymers |
| 08/25/2005 | US20050186587 Method for screening a substance which can suppress degradation of a nuclear receptor or a substance which can promote degradation of a nuclear receptor |
| 08/25/2005 | US20050186582 Compositions and methods of using hexokinase V |
| 08/25/2005 | US20050186577 Using gene expression patterns in response to estrogen exposure as evaluative tool in determining recurrence of mammary gland cell proliferative disorders |
| 08/25/2005 | US20050186576 Polymer sequencing using selectively labeled monomers and data integration |
| 08/25/2005 | US20050186575 Corona-virus-like particles comprising functionally deleted genomes |
| 08/25/2005 | US20050186572 Polymerase extension at 3' terminus of PNA-DNA chimera |
| 08/25/2005 | US20050186571 Diagnosis and prevention of cancer cell invasion |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186566 Detection of modulator of defective cell proliferation; obtain cells with defects in cell proliferation, incubate with modulator, monitor adjustment in cell activity |
| 08/25/2005 | US20050186565 Using spectral-imaging device which utilizes surface plasmon resonance-modified multiband fluorescence polarization and polarized phase shifting of reflected light to screen pharmaceuticals, detect chemical warfare agents and verify microorganismal infection |
| 08/25/2005 | US20050186562 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time |
| 08/25/2005 | US20050186561 Using concentration of macroglobulins, hyaluronic acid (HA) and/or tissue inhibitor of metalloproteinases-1 (TIMP-1) as diagnostic indicators of viral and liver disorders |
| 08/25/2005 | US20050186560 Mammalian cell expressing viral replication protein for use as tool in identifying modulators for treatment of cell proliferative and autoimmune disorders; immunotherapy |
| 08/25/2005 | US20050186559 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease |
| 08/25/2005 | US20050186558 Adenocarcinomal cells for expression of whey protein and/or caseinoglycomacropeptide for use in treatment of diabetes |
| 08/25/2005 | US20050186557 Cytotoxicity assay |
| 08/25/2005 | US20050186556 Kit comprising cell migration apparatus which improves identification and distinction of chemokine receptor antagonists from non-specific blockers |
| 08/25/2005 | US20050186554 Image analysis and assay system |
| 08/25/2005 | US20050186512 Fabrication of a high resolution biological molecule detection device |
| 08/25/2005 | US20050186317 High speed, accuracy; baking batches using various wheat flour; measurement spectra; calibration |
| 08/25/2005 | US20050186287 Use of copper agonists such as divalent metal ions, oligopeptides, oligonucleotides, oligosaccharides, nucleotide analogs that bind to copper binding site of amyloid precursor protein and reduce or prevent release of amyloid A beta peptide; prevention or treatment of Alzheimer's disease |
| 08/25/2005 | US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/25/2005 | US20050186224 Attenuated bovine respiratory syncytial virus |
| 08/25/2005 | US20050186215 CUDR as biomarker for cancer progression and therapeutic response |
| 08/25/2005 | US20050186214 Antiproliferative agents; chimeric molecules to direct cytotoxins, imaging reagents, and drugs; cells, kits |
| 08/25/2005 | US20050186205 Administering unlabelled anti-CD20 antibody that binds to the CD20 antigen present on lymphoma cells; a second treatment of cyclophosphamide, doxorubicin, vincristine or prednisone |
| 08/25/2005 | US20050186203 Isolated antibody bound to human insulin-like growth factor-I receptor, identification of its CDRs (complementarity-determining regions), inhibiting the tyrosine kinase activity of the IGF-IR receptor |
| 08/25/2005 | US20050186201 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis |
| 08/25/2005 | US20050186200 HADHs as modifiers of the p21 pathway and methods of use |
| 08/25/2005 | US20050186162 A case having a storage space and a retrieval port that communicates the storage space with an external space, and a plurality of analytical tools stored in the storage space in a stacked state |
| 08/25/2005 | US20050186148 Prophylaxis or treatment of dental caries, dental plaque, and periodontal infection that include lactic bacteria that are not part of the resident microflora of the mouth, are low acidifying, and are capable of adhering directly to the pellicle of the teeth |
| 08/25/2005 | US20050186136 Soluble JAM-1, 2, and 3 as diagnostic & prognostic markers in cardiovascular, vascular, and inflammatory disorders |
| 08/25/2005 | US20050186129 reducing chloroplatinic acid in the presence of gold particles formed by reducing chloroauric acid, to form platinum particles supported on the surfaces of the gold particles; colloids having high sensitivity, used as labels for immunological measurements and as staining agent for proteins |